Newsweek Asked Whether the Peptide Safety Data Holds Up. Here Is What I Sent.

On July 30, Newsweek ran “Peptides Are the New Longevity Craze. Safety Data Tells a Different Story” by Melissa Fleur Afshar. The reporter asked me. The story ran without my answer.

I have said before that a peptide is a size, not a promise, and that a “research use only” label means nothing. The Newsweek piece was about something narrower and more useful: whether the data behind the craze exists. Mostly, it does not.

Two Camps, Both Right

The researchers in the piece were blunt. Mansoor Amiji of Northeastern: “Except for GLP-1 agonists by Eli Lilly and Novo, and other FDA-approved peptides, there are no preclinical or clinical studies showing safety and effectiveness of these ‘hyped’ peptides.”

The clinicians were practical. Neil Panchal of Longevitix told Newsweek that when peptides are not available through licensed pharmacies, “patients do not stop seeking them; they migrate to gray-market vendors selling material of unverified purity.”

Both are true. One camp is talking about efficacy. The other is talking about supply. The FDA meeting on July 23 was about supply.

What I Told the Reporter

“Allowing a pharmacy to compound it means a pharmacy can make it. Allowing them to make it does not mean it will work. That will likely lead many readers to think the first fact answers the second, which it does not.”

“If some peptides could now go through licensed compounding pharmacies with an actual prescription, that would be safer than the massive, unregulated market people are already buying from on the internet.”

“The big risk is that people read the news and think a scientist gave their blessing simply because it became more available.”

A pharmacy shelf is a manufacturing standard. It tells you the dose on the label is the dose in the vial and that the vial is sterile. That is worth a great deal to me as a surgeon. It is not a clinical trial, and nobody should read it as one.

Where the Data Runs Out, and Where the Harm Starts

“Very few of them know how little human research is available on these compounds, know that most dosage regimens have been picked up from bodybuilding forums, or know that the vial is coming from an overseas research-chemical company, with no guarantee as to contents, purity or whether it is a sterile preparation.”

“I have seen many cases like this, so this is not an isolated case. And the common denominator in all these cases has been that the substances or the peptides have been acquired through unlicensed sources.”

Note what the harm is not. In my clinic it has not been a peptide doing something exotic. It has been an abscess from a dirty vial. The safety data that exists is about the supply chain, and it is ugly.

The Line I Keep Coming Back To

“Peptides are not peptides, and one answer is not the answer. Topical peptides applied to the skin are mostly not toxic and, in most circumstances, they have been exaggerated. Peptides that are compounded or injected are promising enough to merit genuine study, and they are already used a great deal, far ahead of the studies and with almost no supervision.”

The full breakdown, category by category with the table, is on Southwest Plastic Surgery. What I need to know before an operation is on Agullo Plastic Surgery. How a real protocol is monitored is here.

Why Choose Dr. Agullo

I am certified by the American Board of Plastic Surgery and the American Board of Surgery, a Mayo Clinic fellowship-trained plastic surgeon, Clinical Associate Professor of Plastic Surgery at Texas Tech University Health Sciences Center, an editorial board member at Aesthetic Plastic Surgery and Plastic and Reconstructive Surgery Global Open, and a Castle Connolly Top Doctor every year from 2014 through 2026.

Ready to Talk?

If the vial has no label, that is the answer. Call (915) 590-7900, text 1-866-814-0038, or book online at agulloplasticsurgery.com/appointments. #StayBeautiful

Find me at @RealDrWorldWide on Instagram, TikTok, and Snapchat, @Agullo on X, or @AgulloPlasticSurgery on Facebook.